Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide

Edoxaban is the fourth non-vitamin K antagonist oral anticoagulant now available for clinical use in the prevention of stroke/systemic embolism in atrial fibrillation (AF) and in the treatment of venous thromboembolism (VTE), after the completion of large-scale randomized comparative clinical trials...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Adv Ther
Egile Nagusiak: De Caterina, Raffaele, Ageno, Walter, Boriani, Giuseppe, Colonna, Paolo, Ghirarduzzi, Angelo, Patti, Giuseppe, Rossini, Roberta, Rubboli, Andrea, Schinco, Piercarla, Agnelli, Giancarlo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2017
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5350200/
https://ncbi.nlm.nih.gov/pubmed/28194578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-017-0488-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak